The global monkeypox therapeutics and vaccines market and global monkeypox diagnostic kits market from kylie's blog

Post the global outbreak of the monkeypox disease in early 2022, there has been a surge in interest towards research for effective and safe vaccines / therapeutics intended for the management / treatment of disease symptoms

Roots Analysishas announced the addition of “Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits, 2023-2035” report to its list of offerings.

 

Given the increase in research and development activity in this domain and the substantial financial assistance provided by public funding institutes, the monkeypoxtherapeutics / vaccines and diagnostic kits market is projected to grow at a steady pace in the near future. The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease

 

 

Key Market Insights

 

25+ monkeypox therapeuticsand vaccines are currently approved / under development

More than 20% of the aforementioned candidates are approved or have been granted expanded access for the treatment / prevention of monkeypox. Further, 70% of the total candidates are in preclinical stages of development. It is also worth noting that ~65% of the candidates in development pipeline are biologics.

 

Over 120 developers claim to provide diagnostic kits for monkeypox virus detection

Interestingly, nearly 65% of the diagnostic kit providers are based in Asia-Pacific and rest of the world. Notably, around 50% of the total players engaged in this space are mid-sized firms. Additionally, over 75% of monkeypox diagnostic kits use polymerase chain reaction (PCR) as a detection method.

 

Partnership activity within this domain has grown at a CAGR of ~150%, between 2018 and 2022

More than 85% of the partnerships were inked in the year 2022, indicating the recent surge in interest of industry stakeholders in this domain. Further, majority of the deals were supply agreements (75%), and primarily focused on expanding their global reach.

 

More than 250 grants have been awarded for research related to monkeypox therapeutics, vaccines and diagnostic solutions

Close to 40% of the total amount was awarded under the R01 mechanism (which supports research projects). Further, microbiology / immunology / virology departments emerged as the key research departments, having received over 35% of the total grants.

 

Over 230 articles related to monkeypox therapeutics, vaccines and diagnostic kits have been published between 2018 and 2022

35% of the articles published in this domain were research papers, followed by review papers (12%). It is important to note that close to 90% of the total articles were published post-2020, highlighting the growing research activity in the recent years.

 

North America and Europe are anticipated to capture close to 95% share of the monkeypox therapeutics and vaccines market, by 2035

The monkeypox therapeutics / vaccines market’s evolution is likely to be driven by the rising need for novel drug candidates. In terms of type of product, vaccines are expected to occupy a larger share (99%) of the overall monkeypox therapeutics and vaccines market in 2035.

 

PCR Kits are anticipated to capture more than 70% share of the monkeypox diagnostic kits market, by 2035

In the long term, hospitals and clinics are likely to contribute to a majority share (~50%) of revenues as end users. Further, North America and Europe are anticipated to capture close to 70% share of the monkeypox diagnostic kits market.

 

 

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/monkeypox-treatment-market/request-sample.html

 

Key Questions Answered

§  What are the factors driving the overall monkeypox market?

§  Who are the key players engaged in the development of monkeypox therapeutics / vaccines, and diagnostic kits?

§  How many therapeutics and vaccines are approved for the treatment and prevention of monkeypox?

§  What is the count of monkeypox diagnostic kits that are currently available in the market?

§  What are the partnership and collaboration trends observed in relation to monkeypox therapeutics / vaccines and diagnostic kits?

§  Which segment, in terms of type of product, accounts for the largest monkeypox therapeutics / vaccines market share?

§  Which type of diagnostic kit accounts for the largest monkeypox market share?

 

For additional details, please visit 

 https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html